Seer announces new data at HUPO World Congress 2025

Seer (SEER) announced new data to be featured at the Human Proteome Organization, HUPO, World Congress 2025, underscoring how deep, scalable proteomics is transforming the study of human disease. Through a combination of Seer-led, collaborative, and independent studies, the company’s Proteograph Product Suite is powering a growing body of research across cardiovascular, oncology, and aging biology. “Collectively, these findings demonstrate how Seer’s technology is enabling scientists worldwide to translate complex biological signatures into actionable understanding, bringing proteomics to the forefront of translational and population-scale research,” the company said.